UCB Announces Commercial Availability Of Zilbrysq In U.S. To Treat Generalized Myasthenia Gravis

RTTNews | 568 days ago
UCB Announces Commercial Availability Of Zilbrysq In U.S. To Treat Generalized Myasthenia Gravis

(RTTNews) - Biopharmaceutical company UCB announced Wednesday that ZILBRYSQ (zilucoplan) is now available in the U.S. for the treatment of generalized myasthenia gravis (gMG) in adult patients who are anti-acetylcholine receptor (AChR) antibody positive.

ZILBRYSQ was approved by the U.S. Food and Drug Administration (FDA) on October 17, 2023.

ZILBRYSQ is available by prescription as a ready-to-use pre-filled syringe that is a once-daily administration. Healthcare providers who prescribe ZILBRYSQ must enroll in the ZILBRYSQ REMS because of the risk of serious meningococcal infections.

Myasthenia gravis is a rare, chronic, autoimmune neuromuscular disease, which is characterized by muscle weakness that worsens after periods of activity and improves after periods of rest.

read more
Japan Inflation Data Due On Friday

Japan Inflation Data Due On Friday

Japan will on Friday release July figures for Tokyo inflation, highlighting a light day for Asia-Pacific economic activity. In June, both overall and core CPI were up 3.1 percent on year.
RTTNews | 29 minutes ago
Euro Higher Against Majors

Euro Higher Against Majors

The euro climbed against its major counterparts in the New York session on Thursday, as upbeat earnings from Google parent Alphabet lifted tech shares.
RTTNews | 1h 54min ago
Swiss Market Ends Modestly Lower

Swiss Market Ends Modestly Lower

The Switzerland market stayed a bit positive in early trades on Thursday, but retreated around mid morning and then spent the rest of the day's session in negative territory, as investors stayed largely cautious, reacting to earnings and awaiting news from the trade front.
RTTNews | 4h 57min ago
European Stocks Close Broadly Higher

European Stocks Close Broadly Higher

European stocks closed broadly higher on Thursday despite paring most of their early gains, after the European Central Bank left its interest rate unchanged for the first time in a year. The ECB held its key interest rates steady, in line with expectations.
RTTNews | 5h 17min ago
U.S. New Home Sales Rebound Much Less Than Expected In June

U.S. New Home Sales Rebound Much Less Than Expected In June

After reporting a steep drop by new home sales in the U.S. in the previous month, the Commerce Department released a report on Thursday showing a modest rebound by new home sales in the month of June. The Commerce Department said new home sales rose by 0.6 percent to an annual rate of 627,000 in June after plummeting by 11.6 percent to a rate of 623,000 in May.
RTTNews | 7h 10min ago
U.S. Initial Jobless Claims Unexpectedly Dip To 217,000

U.S. Initial Jobless Claims Unexpectedly Dip To 217,000

The Labor Department released a report on Thursday unexpectedly showing another modest decrease by first-time claims for U.S. unemployment benefits in the week ended July 19th. The report said initial jobless claims edged down to 217,000, a decrease of 4,000 from the previous week's unrevised level of 221,000. Economists had expected jobless claims to rise to 227,000.
RTTNews | 7h 52min ago
ECB Leaves Rates Unchanged As Expected

ECB Leaves Rates Unchanged As Expected

The European Central Bank held its key interest rates steady on Thursday, in line with expectations, as policymakers assessed that price pressures continue to ease, but acknowledged that the economic environment remains highly uncertain mainly due to the trade tariff wars.
RTTNews | 8h 36min ago